卵泡树突细胞肉瘤患者的生存分析:一个基于人口的研究
Siyu Chen1, Yue Sun1, Wei Sun1
1Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Hematology (Amsterdam, Netherlands)
|September 21, 2023
概括
毛囊树突细胞肉瘤 (FDCS) 是罕见的. 5年后生存率显著改善,但年龄和转移性疾病等风险因素会影响结果. 手术对患者有好处,而辅助疗法则没有生存优势.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 流行病学 流行病学
背景情况:
- 状树突细胞肉瘤 (FDCS) 是一种罕见的恶性瘤,发表的临床数据有限.
- 之前没有研究过FDCS患者的有条件生存率.
研究的目的:
- 分析FDCS患者的临床过程和生存结果.
- 为了确定预后因素,并评估FDCS的治疗疗效.
主要方法:
- 从监测,流行病学和最终结果 (SEER) 数据库中对187名FDCS患者的回顾性分析.
- 评估整体存活率 (OS),FDCS特定存活率和条件存活率.
- 确定与生存相关的因素,包括年龄,疾病阶段,主要部位和治疗方式.
主要成果:
- 诊断时的中位数年龄为50岁,腹部/骨盆是最常见的初级部位.
- 五年生存率为59.8%,条件生存率在5年生存者中增加到83.8%.
- 年龄超过60岁,转移性疾病和胸部FDCS与较差的生存率有关. 手术改善了结果,但辅助放射治疗/化疗并没有显著提高存活率.
结论:
- FDCS存活率受到年龄,转移状态和原发性瘤位置的影响.
- 手术是FDCS的有益治疗方法,无论疾病的阶段如何.
- 局部疾病的辅助疗法似乎没有改善存活率,这表明需要改进治疗和监测策略.
相关概念视频
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Comparing the Survival Analysis of Two or More Groups
218
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
218


